🇺🇸 FDA
Patent

US 10421964

UNA oligomers and compositions for treating amyloidosis

granted A61KA61K31/685A61K31/713

Quick answer

US patent 10421964 (UNA oligomers and compositions for treating amyloidosis) held by ARCTURUS THERAPEUTICS, INC. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/685, A61K31/713, A61K9/0019, A61K9/127